Aldeyra Therapeutics (ALDX) Tops Q1 EPS by 3c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• Accenture downgraded by TD Cowen on AI concerns